Log In
Print
BCIQ
Print
Print this Print this
 

Targin, oxycodone/naloxone

  Manage Alerts
Collapse Summary General Information
Company Mundipharma International Ltd.
DescriptionProlonged-release combination of oxycodone and naloxone
Molecular Target Kappa opioid receptor (OPRK1) (KOR) ; Mu opioid receptor (OPRM1) (MOR)
Mechanism of ActionMu opioid receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsTreat severe pain that can only be adequately managed with opioid analgesics
Regulatory Designation

Partner

Shionogi & Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today